With deaths from obesity-related heart disease reportedly increasing by 180% over the past 20 years, more research is being done to learn how GLP-1 medications such as Ozempic, Wegovy, Mounjaro and ...

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...

GLP-1R injectable drugs are effective in treating obesity, but their success points to a gap in the market: oral alternatives.

Clinicians and patients should avoid using compounded GLP-1 products that are not FDA-approved, the American Diabetes Association wrote in a guidance statement published Dec. 2 in Diabetes Care. The ...

Learn how future-focused leaders can identify business threats, navigate risks, and maintain a competitive edge with insights ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

New Jerseyans are worried about the cost of services, unexpected medical bills, monthly premiums and prescription drug costs, ...

From the column: "(Trump's new Department of Government Efficiency) could turn out to be a worthwhile enterprise, deserving ...

Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...

While Ozempic bodes well for weight loss, some users are concerned the drug's impact also means unwanted changes to their ...